Oportuzumab (Anti-EpCAM / TROP1 / CD326)
A2992
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameOportuzumab (Anti-EpCAM / TROP1 / CD326)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionOportuzumab (Anti-EpCAM / TROP1 / CD326) is a humanized monoclonal antibody targeting EpCAM. It exhibits potential in treatment of bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. MW :145.4 KD.
- Storage Instruction-20°C
- UNSPSC12352203